Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...
FDA designations and new study publications Recent developments include Phase 2 DMD Study Breakthrough Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback